Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LGND > SEC Filings for LGND > Form 8-K/A on 22-Jan-2013All Recent SEC Filings

Show all filings for LIGAND PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K/A for LIGAND PHARMACEUTICALS INC


22-Jan-2013

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Base Salary Increases and Payment of Bonuses to Named Executive Officers

On January 16, 2013, the Board of the Company approved base salary increases for 2013 and cash bonus payments for the 2012 fiscal year to be paid to the Company's named executive officers. Under the Company's bonus program, the target performance bonus for John L. Higgins, the Company's President and Chief Executive Officer, is 75% of base salary, the target bonus for Matthew W. Foehr, the Company's Executive Vice President and Chief Operating Officer, is 50% of base salary and the target bonus for the other named executive officers is 40% of base salary. Bonus payments were based on the Board's evaluation of performance goals for 2012. Such goals related to the achievement of certain corporate organizational and infrastructure objectives and the advancement of the Company's clinical development programs.

The salary increases were previously reported incorrectly and certain figures below in the column marked "2013 Base Salary" have been revised to reflect the actual increases.

Name and Title                           2013 Base Salary          2012 Bonus
John L. Higgins,                             $500,780               $363,388
President and Chief Executive
Officer
Matthew W. Foehr, Executive Vice             $368,431               $179,813
President and Chief Operating
Officer
John P. Sharp,                               $301,490               $102,382
Vice President, Finance and Chief
Financial Officer
Charles S. Berkman, Vice President,          $283,605               $110,081
Secretary and General Counsel
Nishan de Silva, M.D., M.B.A.,               $295,000                $98,508
Vice President of Corporate
Development


  Add LGND to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LGND - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.